Actinium Pharmaceuticals, Inc. 10-K filing
Filed 2026-03-30 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001213900-26-036504
- Form type
- 10-K
- CIK
- 0001388320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1388320/000121390026036504/ea0279291-10k_actinium.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Actinium Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $90,000 | - | - |
| Operating Income | $-36.2M | - | - |
| Net Income | $-33.9M | - | - |
| Eps Basic | -1.09 | - | - |
| Eps Diluted | -1.09 | - | - |
| Cash And Equivalents | $48.0M | - | - |
| Total Assets | $51.8M | - | - |
| Total Liabilities | $43.9M | - | - |
| Shareholders Equity | $7.8M | - | - |
| Operating Cash Flow | $-24.6M | - | - |
| Capital Expenditures | $104,000 | - | - |